Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 1st Quarter - Report

PHOENIX CAPITAL MANAGEMENT LLC

via POLICY ADVOCATES

1st Quarter (Jan 1 - Mar 31) · 2010Posted Apr 19, 2010Filing document ↗LDA record ↗

Income$17Kfee reported

Client

Name: PHOENIX CAPITAL MANAGEMENT LLC
Description: Internet Pharmacy.
Location: * Undetermined

Registrant

Firm: POLICY ADVOCATES
Description: Walker, Martin & Hatch provides regulatory and legislative consulting services.
Location: Arlington, Virginia, United States of America

Lobbying activities

2 issues

Health Issues
HR 3590, Patient Protection and Affordable Care Act. Track and monitor. HR 3962, Affordable Health Care for America Act. Track and monitor. S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009. Track and monitor.
LobbyistsSCOTT HATCH · JACK MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Track and monitor Internet Pharmacy Issues.
LobbyistsJACK MARTIN · LAIRD WALKER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

PHOENIX CAPITAL MANAGEMENT LLC — Lobbying — Receipts Report